• 1. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Professional Introduction to 1-(2,6-Dichlorophenyl)ethanol (CAS No. 53066-19-6)

1-(2,6-Dichlorophenyl)ethanol, identified by its Chemical Abstracts Service Number CAS No. 53066-19-6, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, characterized by its dichlorophenyl and ethanol functional groups, has garnered attention due to its versatile applications in medicinal chemistry and industrial processes.

The structural motif of 1-(2,6-Dichlorophenyl)ethanol consists of a benzene ring substituted with two chlorine atoms at the 2 and 6 positions, linked to an ethanol side chain. This unique arrangement imparts distinct chemical properties that make it a valuable intermediate in the synthesis of various pharmacologically active agents. The presence of both electron-withdrawing chlorine atoms and a hydroxyl group enhances its reactivity, facilitating diverse chemical transformations.

In recent years, 1-(2,6-Dichlorophenyl)ethanol has been extensively studied for its role in developing novel therapeutic compounds. Researchers have leveraged its structural features to design molecules with potential applications in treating neurological disorders, inflammatory conditions, and infectious diseases. The dichlorophenyl moiety is particularly noteworthy for its ability to modulate enzyme activity and interact with biological targets.

One of the most compelling aspects of CAS No. 53066-19-6 is its utility in the synthesis of heterocyclic compounds. The ethanol group can undergo various reactions such as esterification, etherification, and oxidation, allowing for the creation of complex molecular architectures. These transformations are crucial in drug discovery pipelines, where intermediates like 1-(2,6-Dichlorophenyl)ethanol serve as building blocks for more intricate pharmacophores.

The pharmaceutical industry has shown particular interest in derivatives of 1-(2,6-Dichlorophenyl)ethanol due to their demonstrated biological activity. For instance, studies have indicated that certain analogs exhibit inhibitory effects on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are implicated in pain and inflammation pathways. Additionally, modifications to the ethanol group have led to compounds with enhanced solubility and metabolic stability.

Advances in computational chemistry have further highlighted the importance of CAS No. 53066-19-6 as a scaffold for drug design. Molecular modeling techniques have been employed to predict the binding affinity of various derivatives to biological targets, streamlining the process of identifying lead compounds. These computational approaches complement experimental efforts by providing rapid screening tools for optimizing molecular properties.

The industrial synthesis of 1-(2,6-Dichlorophenyl)ethanol involves multi-step organic reactions that require precise control over reaction conditions. Recent innovations in catalytic systems have improved the efficiency and selectivity of these processes, reducing waste and energy consumption. Such advancements align with global trends toward sustainable manufacturing practices in the chemical industry.

In conclusion, 1-(2,6-Dichlorophenyl)ethanol (CAS No. 53066-19-6) represents a cornerstone compound in modern pharmaceutical research. Its unique structural features and reactivity make it indispensable for developing novel therapeutic agents across multiple disease areas. As research continues to uncover new applications for this molecule, its significance in medicinal chemistry is poised to grow even further.

• 14299-54-8(Benzenemethanol,2,4,5-trichloro-a-methyl-)
• 1475-13-4(1-(2,4-Dichlorophenyl)ethanol)
• 6335-15-5(bis(2-Chlorophenyl)methanol)
• 43171-49-9((2-Chlorophenyl)(4-chlorophenyl)methanol)
• 16071-26-4(Benzenemethanol,2-chloro-a-phenyl-, (aR)-)
• 14866-28-5(1-(2,4-Dichlorophenyl)-1,2-ethanediol)
• 13524-04-4(1-(2-Chlorophenyl)ethanol)
• 131864-71-6((S)-1-(2-Chlorophenyl)ethanol)
• 120466-66-2((R)-1-(2-Chlorophenyl)ethanol)
• 586418-00-0(1,2-Ethanediol, 1-(2,4-dichlorophenyl)-, (1R)-)